FY09 DoD Peer Reviewed Orthopaedic Research Program Translational Research Partnership Award | Apply Online

FY09 DoD PRORP Translational Research Partnership Award (TRPA) - FAQs

What is the FY09 DoD Peer Reviewed Orthopaedic Research Program (PRORP) Translational Research Partnership Award (TRPA)?

The TRPA is a U.S. Department of Defense funding opportunity under the Peer Reviewed Orthopaedic Research Program (PRORP) designed to speed the translation of promising orthopaedic research ideas into practical clinical use. It emphasizes teamwork that deliberately connects laboratory discovery with clinical needs so concepts can move toward patient-ready solutions more directly than they might if investigators worked separately.

What is the main goal of this award?

The core goal is to build strong, multi-institutional and multidisciplinary partnerships that move orthopaedic research from the lab toward clinical application. The program is explicitly oriented toward translation, meaning it prioritizes work that has a clear path toward real-world use.

What types of problems or injuries is the program focused on?

The program is particularly focused on orthopaedic injuries relevant to military combat. Proposed work should have clear potential to improve prevention, diagnosis, treatment, rehabilitation, or long-term outcomes for injuries commonly seen in service members.

What does "translational" mean in the context of this opportunity?

In this opportunity, "translational" refers to research designed to bridge laboratory discovery and clinical needs, with the intent of moving concepts toward clinical use. The award is aimed at accelerating progress where it would likely be slower or less feasible if investigators were working independently.

Is a partnership required to apply?

Yes. A defining feature of the TRPA is its required partnership and team structure. Applications must be submitted by a partnership rather than by a single-investigator effort.

How many key participants can be included in the partnership?

The partnership can include up to four key participants.

What roles must be represented on the team?

The partnership must include clinicians and laboratory scientists, with at least one person in each category. A purely basic science team or a purely clinical team would not meet the intent described for this award.

Does the team need orthopaedic-specific expertise?

Yes. At least one member of the partnership must have direct experience in orthopaedic research or orthopaedic medicine. This requirement helps ensure the collaboration is grounded in real orthopaedic expertise.

Are new investigators eligible, or is this intended only for established teams?

The award is designed to support both new and established investigators. The description indicates openness to teams that mix early-career talent with senior leadership, as long as the collaboration is credible and positioned to make meaningful progress.

Are military collaborators required?

The opportunity strongly encourages (but does not explicitly state as mandatory in the provided information) partnerships that bring together academic institutions or government agencies with military investigators and/or military clinicians. This emphasis reflects the program's translational focus and desire for outcomes that can realistically be adopted in military medicine.

Why does the program encourage partnerships with military investigators or clinicians?

The program aims for science that is informed by real-world military clinical problems and that produces outcomes that can be adopted in military medicine. In practical terms, this may involve clinically relevant models, access to patient populations or military treatment facility insight, and an implementation path that accounts for combat-related injury care.

Who issued this funding opportunity?

The opportunity was issued by the Department of the Army through USAMRAA (as stated in the announcement details provided).

What is the Funding Opportunity Number for this award?

The Funding Opportunity Number is W81XWH-09-PRORP-TRPA.

What funding instrument types are associated with this opportunity?

The listed instrument types include both a cooperative agreement and a grant. This suggests awards could involve varying levels of government involvement or coordination depending on the mechanism used.

What is the activity category for this program?

The activity category is Science and Technology and other Research and Development.

What CFDA program is associated with this opportunity?

The CFDA program associated with this opportunity is 12.420 (Military Medical Research and Development).

How many awards were anticipated?

The program anticipated making about three awards.

What was the estimated total funding amount available?

The estimated total funding amount across the competition was $3,500,000.

Is cost sharing or matching required?

No. Cost sharing or matching was not required.

Who was eligible to apply?

Eligibility was listed as unrestricted, meaning the opportunity was broadly open to many types of applicant organizations, subject to any additional eligibility clarifications in the full announcement.

When was the opportunity posted?

The announcement was posted and created on July 14, 2009.

What was the application deadline?

The original and final closing date was November 17, 2009.

When was the opportunity archived?

The archive date was December 17, 2009.

Who should be contacted for help accessing the full announcement?

For assistance accessing the full announcement, contact PA HELP at 301-619-7079 or email cdmrp.pa@amedd.army.mil.

Who should be contacted for eReceipt/CDMRP submission support?

For eReceipt/CDMRP submission support, contact 301-682-5507 or email help@cdmrp.org.